fda warning letters glp-1 compounding september 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading FDA Targets GLP-1 and Peptide

They observed a drop in that motivation as the mice ran roughly 40% less total distance and made about 25% fewer efforts to unlock the wheel, said Ralph DiLeone, a neuroscientist who presented his teams preliminary findings at the Society for Neurosciences annual meeting in October in Chicago

Additionally, patients need to purchase injection supplies such as needles and sharps containers, though these are relatively inexpensive (usually under 10 monthly)

For most patients with obesity, the cardiovascular and metabolic benefits of these medications substantially outweigh theoretical concerns about blood clots, which are not supported by current evidence

It should be mentioned that all the most effective GLP-1 drugs are currently delivered using injectable pens, which makes this type of drug delivery system more popular among healthcare professionals and patients

As the new MDL moves forward, Judge Marston will oversee pretrial proceedings, including discovery and expert testimony, in a case that could have major implications for drug safety oversight and one of the most lucrative pharmaceutical markets in recent years